Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ide, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ide, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:412-423, 2005
© 2005 by the American Diabetes Association, Inc.

Interaction of Fish Oil and Conjugated Linoleic Acid in Affecting Hepatic Activity of Lipogenic Enzymes and Gene Expression in Liver and Adipose Tissue

Takashi Ide

From the Laboratory of Nutritional Biochemistry, National Food Research Institute, Tsukuba Science City, Japan

The interaction of dietary fish oil and conjugated linoleic acid (CLA) in affecting the activity of hepatic lipogenic enzymes and gene expression in liver and adipose tissue was examined in mice. A diet containing 1.0% CLA, mainly composed of 9cis,11trans- and 10trans,12cis-octadecadienoic acids at equivalent amounts, greatly decreased adipose tissue weight and serum concentrations of leptin and adiponectin and was accompanied by a downregulation of the expression of various adipocyte-abundant genes in epididymal adipose tissue. However, CLA increased the serum insulin concentration fourfold, and it caused hepatomegaly, with huge increases in the triacylglycerol level and the activity and mRNA levels of hepatic lipogenic enzymes. Different amounts (1.5, 3, and 6%) of fish oil added to CLA-containing diets dose-dependently downregulated parameters of lipogenesis and were accompanied by a parallel decrease in the triacylglycerol level in the liver. The supplementation of CLA-containing diets with fish oil was also associated with an increase in fat pad mass and mRNA levels of many adipocyte-abundant genes in epididymal adipose tissue along with a normalization of serum concentrations of leptin and adiponectin in a dose-dependent manner. However, in mice fed a diet containing 1.5% fish oil and CLA in whom fat pad mass was still low and comparable to that in the animals fed CLA alone, the serum insulin concentration greatly exceeded (twofold) the value observed in mice fed CLA alone, indicating an aggravation of insulin resistance. This hyperinsulinemia was ameliorated with increasing amounts of fish oil in the diets. Apparently, many of the physiological effects of CLA can be reversed by fish oil.


Address correspondence and reprint requests to Dr. Takashi Ide, Laboratory of Nutritional Biochemistry, National Food Research Institute, 2-1-12 Kannondai, Tsukuba Science City 305-8642, Japan. E-mail: idetaka{at}nfri.affrc.go.jp

Abbreviations: ABCA1, ATP-binding cassette transporter A1; CLA, conjugated linoleic acid; IL, interleukin; LXR, liver X receptor; PPAR, peroxisome proliferator-activated receptor; SREBP, sterol regulatory element-binding protein; TNF-{alpha}, tumor necrosis factor-{alpha}; UCP, uncoupling protein


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
V. Saraswathi, L. Gao, J. D. Morrow, A. Chait, K. D. Niswender, and A. H. Hasty
Fish Oil Increases Cholesterol Storage in White Adipose Tissue with Concomitant Decreases in Inflammation, Hepatic Steatosis, and Atherosclerosis in Mice
J. Nutr., July 1, 2007; 137(7): 1776 - 1782.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L.-F. Liu, A. Purushotham, A. A. Wendel, and M. A. Belury
Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1671 - G1682.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. Degrace, B. Moindrot, I. Mohamed, J. Gresti, Z.-Y. Du, J.-M. Chardigny, J.-L. Sebedio, and P. Clouet
Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid
J. Lipid Res., December 1, 2006; 47(12): 2647 - 2655.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Ferramosca, V. Savy, L. Conte, S. Colombo, A. W. C. Einerhand, and V. Zara
Conjugated linoleic acid and hepatic lipogenesis in mouse: role of the mitochondrial citrate carrier
J. Lipid Res., September 1, 2006; 47(9): 1994 - 2003.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Hashimoto, N. Shimizu, T. Kimura, Y. Takahashi, and T. Ide
Polyunsaturated Fats Attenuate the Dietary Phytol-Induced Increase in Hepatic Fatty Acid Oxidation in Mice
J. Nutr., April 1, 2006; 136(4): 882 - 886.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. S. Winzell, G. Pacini, and B. Ahren
Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E347 - E354.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Ghafoorunissa, A. Ibrahim, L. Rajkumar, and V. Acharya
Dietary (n-3) Long Chain Polyunsaturated Fatty Acids Prevent Sucrose-Induced Insulin Resistance in Rats
J. Nutr., November 1, 2005; 135(11): 2634 - 2638.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.